LONA

LeonaBio Inc. Common Stock (LONA)

Stock · NASDAQ · Health Care

$5.26as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

LeonaBio appears among health‑care stocks moving intraday. LeonaBio was listed among twelve health‑care stocks that showed notable price movement on Monday and again on Friday, according to Benzinga. The mentions suggest the stock experienced intraday volatility during those sessions. With the RSI currently low and the price near a recent support level, the recent activity aligns with a broader sector‑wide movement.

Active signals

High Beta47.9%
200 SMA Touch0.0%
Resistance level
$8.32
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

What LONA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike45-5.4%44%
Bollinger Band Breakdown230.0%48%
Bollinger Band Breakout23-3.5%48%
200-Day Moving Average TouchActive now11-5.1%45%
Any 20-session window (baseline)-2.1%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About LONA

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or…

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Employees
19

Fundamentals

1-day range
$4.91$5.42
Market cap
$73.36M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-19.72
Dividend yield
—
Beta
2.00
Avg. volume
191.1K
52-week range
$2.21$14.21
Next earnings: August 6, 2026 · EPS estimate $-1.36confirmed

Forecasts

3 analyst ratings

Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$20
+280.2%
Median
$17
+223.2%
Low
$15
+185.2%

LeonaBio Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • LONA
    LeonaBio Inc. Common Stock
    $5.2
    ▼ 1.70%
    Market cap $73.36MP/E —
    $2.21$14.21
  • ATRA
    Atara Biotherapeutics Inc. Common Stock
    $9.18
    ▼ 4.87%
    Market cap $74.33MP/E —
    $3.92$19.15
  • CSBR
    Champions Oncology Inc. Common Stock
    $4.7
    ▼ 1.88%
    Market cap $72.11MP/E —
    $4.59$8.31
  • CRDF
    Cardiff Oncology Inc. Common Stock
    $0.9
    ▼ 7.22%
    Market cap $74.71MP/E —
    $0.7566$3.31
  • ELOX
    Eloxx Pharmaceuticals Inc. Common Stock
    $13.03
    ▼ 4.89%
    Market cap $71.48MP/E —
    $0$23.4
  • IMA
    ImageneBio Inc. Common Stock
    $4.04
    ▲ 0.25%
    Market cap $63.50MP/E —
    $3.9$9.1
  • GNTA
    Genenta Science S.p.A. American Depositary Shares
    $0.675
    ▲ 0.90%
    Market cap $63.16MP/E —
    $0.55$10

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
371.0K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
6.41M
Total value held
$65.47M
Institutional holders
36
Top holders this quarter
  • Unknown1.86M
  • Unknown727.5K
  • Unknown634.5K
  • Unknown464.4K
  • Unknown464.4K
  • Unknown464.4K
  • Unknown393.7K
  • Unknown393.7K
  • Unknown194.8K
  • Unknown164.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.